Literature DB >> 2493386

Aldose reductase and polyol in cultured pericytes of human retinal capillaries.

T C Hohman1, C Nishimura, W G Robison.   

Abstract

Aldose reductase has been found in several tissues involved in the various complications of long-term diabetes. Since the loss of intramural pericytes is typical of early microangiopathy of the diabetic retina, the presence of aldose reductase and its activity were investigated in pericytes cultured from capillaries of human retinas. Verification that contaminating cells had been removed was made on the basis of the pericytes' distinctive appearance in culture, inability to internalize acetylated-low-density lipoprotein, and immunoreactivity for muscle actin. Using pure cultures of human pericytes, the presence of aldose reductase was demonstrated immunohistochemically with antibodies directed against human placental aldose reductase, and aldose reductase activity was shown biochemically by monitoring the accumulating of xylitol in cells incubated with xylose. Xylitol accumulation was inhibited by the inclusion of an aldose reductase inhibitor in the xylose-containing medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493386     DOI: 10.1016/0014-4835(89)90018-3

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

1.  Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat.

Authors:  A A Sima; W X Zhang; P V Cherian; S Chakrabarti
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.

Authors:  Yukihiko Suzuki; Mitsuru Nakazawa; Kaori Suzuki; Hitoshi Yamazaki; Yasuhiro Miyagawa
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

3.  Polyol formation in cell lines of rat retinal capillary pericytes and endothelial cells (TR-rPCT and TR-iBRB).

Authors:  Peter F Kador; James Randazzo; Karen Blessing; Jun Makita; Peng Zhang; Kuang Yu; Ken-Ichi Hosoya; T Terasaki
Journal:  J Ocul Pharmacol Ther       Date:  2009-08       Impact factor: 2.671

4.  Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

5.  Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs.

Authors:  T A Gardiner; A W Stitt; H R Anderson; D B Archer
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

6.  Pericyte mitogenic activity is reduced in the blood of type 1 diabetic patients with and without retinopathy.

Authors:  F M Williams; A A Dosso; E M Kohner; M Porta
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1.

Authors:  Elizabeth A Scheef; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-04       Impact factor: 4.249

8.  A systematic meta-analysis of genetic association studies for diabetic retinopathy.

Authors:  Sotoodeh Abhary; Alex W Hewitt; Kathryn P Burdon; Jamie E Craig
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

9.  Lipoprotein(a) serum levels in diabetic patients with retinopathy.

Authors:  Giulia Malaguarnera; Caterina Gagliano; Claudio Bucolo; Marco Vacante; Salvatore Salomone; Michele Malaguarnera; Daniela Giovanna Leonardi; Massimo Motta; Filippo Drago; Teresio Avitabile
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

10.  Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.

Authors:  G Bhanuprakash Reddy; A Satyanarayana; N Balakrishna; Radha Ayyagari; M Padma; K Viswanath; J Mark Petrash
Journal:  Mol Vis       Date:  2008-03-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.